RARA CRAFT DATABASE for FDA Medical Devices
510(k)K212613

FDA DEVICE FACTS

Powder Free Nitrile Examination Gloves, Non-sterile,Tested For Use with Chemotherapy Drugs and Opioid Fentanyl Citrate (Blue)

Koon Seng Sdn Bhd

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 21, 2021PRODUCT CODELZA

Indications for use

A Nitrile powder free examination glove is a disposable device intended for medical purposes, worn on the examiner's hand or finger to prevent contamination between examiner and patient. This specialty glove has also been tested with Chemotherapy drugs and the Opioid Fentanyl citrate. Chemotherapy Drugs and the opioid Fentanyl citrate were tested for breakthrough detection times: TEST CHEMOTHERAPY DRUG CONCENTRATION TESTED MINIMUM BREAKTHROUGH DETECTION TIME (MINUTES) Carmustine (BCNU) 3.3 mg/mi 13.0 Cisplatin 1.0 mgml No Breakthrough Up To 240 minutes Cyclophosphamide (Cytoxan) 20.0 mg/ml No Breakthrough Up To 240 minutes Cylarabine 100.0 mg/ml No Breakthrough Up To 240 minutes Dacarbazine (DTIC) 10.0 mg/ml No Breakthrough Up To 240 minutes Doxorubicin Hydrochloride 2.0 mg/mi No Breakthrough Up To 240 minutes Etoposide (Toposar) 20.0 mg/ml No Breakthrough Up To 240 minutes Fluorouracil 50.0 mg/ml No Breakthrough Up To 240 minutes 50 0 mg/m I No Breakthrough Up To 240 minutesIfosfamide No Breakthrough Up To 240 minutes25.0 mg/mlMethotrexate No Breakthrough Up To 240 minutesMitomycin C 0.5 mg/mI 2.0 mg/ml No Breakthrough Up To 240 minutesMitoxantrone 6.0 mgimI No Breakthrough Up To 240 minutesPaclitaxel (Taxol) Thiotepa 10.0 mg/ml 37.9 1.0 mg/mi No Breakthrough Up To 240 minutesVincristine Sulfate Important: Carmustine and Thiotepa have extremely low minimal breakthrough times of 13.0 minutes and 37.9 minutes respectively. Warning: Do not use with Carmustine or Thiotepa. I CONCENTRATION TESTED MINIMUM BREAKTHROUGH DETECTION TIME (MINUTES)TEST OPIOID DRUG Fentanyl Citrate (Injectable) 100 0 mg/2ml No Breakthrough up to 240 minutes

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026